SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808805-22-000093
Filing Date
2022-08-16
Accepted
2022-08-16 20:19:19
Documents
1
Period of Report
2022-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166069554291105.html 4  
1 FORM 4 wf-form4_166069554291105.xml 4 5657
  Complete submission text file 0001808805-22-000093.txt   7147
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address
Murphy Matthew B. (Reporting) CIK: 0001865778 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 221171812